Drug General Information
Drug ID
D0W8NK
Former ID
DNC014323
Drug Name
9-Ethyl-2-methyl-beta-carboline-2-ium iodide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530824]
Structure
Download
2D MOL

3D MOL

Formula
C14H15IN2
Canonical SMILES
CCN1C2=CC=CC=C2C3=C1C=[N+](C=C3)C.[I-]
InChI
1S/C14H15N2.HI/c1-3-16-13-7-5-4-6-11(13)12-8-9-15(2)10-14(12)16;/h4-10H,3H2,1-2H3;1H/q+1;/p-1
InChIKey
CXOKYFSDDOJXHF-UHFFFAOYSA-M
PubChem Compound ID
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [530824]
Cholinesterase Target Info Inhibitor [530824]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer PathwayWP229:Irinotecan Pathway
References
Ref 530824J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.
Ref 530824J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.